Status:
COMPLETED
Human Selenoprotein P Concentration With Glucose Tolerance Status
Lead Sponsor:
Korea University
Conditions:
SEPP1 Levels in Differnet Glucose Tolerance Status
Eligibility:
All Genders
20-80 years
Brief Summary
Recently, seslenium(Se) has known as important regulator in metabolic status, lipid profile, atherosclerosis progression. SEPP1(selenoprotein P1)is a secreted protein from mainly liver. This protein i...
Eligibility Criteria
Inclusion
- 20-80 years old
- Not severe medical condition
Exclusion
- metformin, insulin using type 2 diabetes
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01258426
Last Update
December 13 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.